Novartis Ag (NVS) Ending Cash Balance (2009 - 2026)
Novartis Ag (NVS) reported Ending Cash Balance of $7.62 billion for Q2 2026, up 14.4% from $6.66 billion a year earlier but down 33.4% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2025, Novartis Ag posted Ending Cash Balance of $11.44 billion, down 0.2% from FY2024.
- Ending Cash Balance has a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- By year, Ending Cash Balance came in at $11.46 billion in FY2024 (-14.4%), $13.39 billion in FY2023 (+78.2%), $7.52 billion in FY2022 (-39.4%) and $12.41 billion in FY2021 (+28.5%).
- Five-year quarterly Ending Cash Balance spans a low of $3.63 billion in Q2 2022 and a high of $13.85 billion in Q1 2022.
- Year over year, Ending Cash Balance gained in two of the last eight quarters, with an average decline of 6.3%.
- The high point for year-over-year Ending Cash Balance in five years was Q2 2023 (growth of 200.3%); the low point was Q4 2022 (a decline of 39.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.44 billion (Q1 2026), $11.44 billion (Q4 2025) and $9.56 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,254.27 Bn | 1,227.89 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 640.54 Bn | 560.40 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.61 Bn | 477.72 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.53 Bn | 310.91 Bn | 12.21 Bn | 6.89 Bn |
| 5 | Novartis Ag | 308.44 Bn | 281.67 Bn | - | - |
| 6 | Astrazeneca | 284.15 Bn | 258.04 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.07 Bn | 204.47 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 208.41 Bn | 182.60 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 170.71 Bn | 117.36 Bn | 10.94 Bn | 1.03 Bn |
| 10 | Vertex Pharmaceuticals | 134.82 Bn | 106.82 Bn | 2.84 Bn | 6.15 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.62 Bn |
| Mar 31, 2026 | 11.44 Bn |
| Dec 31, 2025 | 11.44 Bn |
| Sep 30, 2025 | 9.56 Bn |
| Jun 30, 2025 | 6.66 Bn |
| Mar 31, 2025 | 11.46 Bn |
| Dec 31, 2024 | 11.46 Bn |
| Sep 30, 2024 | 13.61 Bn |
| Jun 30, 2024 | 7.90 Bn |
| Mar 31, 2024 | 13.39 Bn |
| Dec 31, 2023 | 13.39 Bn |
| Sep 30, 2023 | 12.41 Bn |
| Jun 30, 2023 | 10.89 Bn |
| Mar 31, 2023 | 12.00 Bn |
| Dec 31, 2022 | 7.52 Bn |
| Sep 30, 2022 | 8.73 Bn |
| Jun 30, 2022 | 3.63 Bn |
| Mar 31, 2022 | 13.85 Bn |
| Dec 31, 2021 | 12.41 Bn |
| Sep 30, 2021 | 7.21 Bn |
API Access
Novartis Ag Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();